HSIC HENRY SCHEIN INC
Wholesale-Medical, Dental & Hospital Equipment & Supplies · Nasdaq · SEC CIK 1000228 · Fiscal year ends 12/26
Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.2%
TTM net income YoY7.7%
TTM EPS YoY15.1%
Revenue 3-yr CAGR2.7%
Net income 3-yr CAGR-1.8%
Margins
Gross margin31.6%
Operating margin5.2%
Net margin3.1%
FCF margin4.1%
EBITDA margin7.6%
Returns
ROE12.9%
ROA3.7%
ROIC (approx.)8.5%
Asset turnover1.22x
Leverage & solvency
Liabilities / assets58.9%
Debt / equity1.07x
Current ratio1.33x
Interest coverage4.35x
Cash quality & payout
Operating cash flow / net income1.63x
Accruals ratio-2.4%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-27 | FY20242024-12-28 | FY20232023-12-30 | FY20222022-12-31 | FY20212021-12-25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Cost of revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B |
| Gross profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B |
| SG&A expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B |
| Operating income | $653.00M | $621.00M | $615.00M | $747.00M | $852.00M |
| Interest expense | $150.00M | $131.00M | $87.00M | $35.00M | $27.00M |
| Pretax income | $533.00M | $513.00M | $542.00M | $721.00M | $831.00M |
| Income tax | $126.00M | $128.00M | $120.00M | $170.00M | $198.00M |
| Net income | $398.00M | $390.00M | $416.00M | $538.00M | $631.00M |
| EBITDA | $964.00M | $918.00M | $863.00M | $959.00M | $1.06B |
| EPS (basic) | 3.29 | 3.07 | 3.18 | 3.95 | 4.51 |
| EPS (diluted) | 3.27 | 3.05 | 3.16 | 3.91 | 4.45 |
| Weighted avg. shares (diluted) | 121.72M | 127.78M | 131.75M | 137.76M | 141.77M |
| Balance sheet | |||||
| Cash & equivalents | $156.00M | $122.00M | $171.00M | $117.00M | $118.00M |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B |
| Current assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B |
| PP&E, net | $621.00M | $531.00M | $498.00M | $383.00M | $366.00M |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B |
| Intangibles | $1.02B | $1.02B | $916.00M | $587.00M | $668.00M |
| Total assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B |
| Current liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B |
| Short-term debt | $764.00M | $650.00M | $264.00M | $103.00M | $51.00M |
| Long-term debt | $2.31B | $1.83B | $1.94B | $1.04B | $811.00M |
| Total debt | $3.07B | $2.48B | $2.20B | $1.14B | $862.00M |
| Total liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B |
| Shareholders' equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B |
| Net debt | $2.92B | $2.36B | $2.03B | $1.03B | $744.00M |
| Shares outstanding | 115.77M | 124.16M | 129.25M | 131.79M | 137.15M |
| Cash flow statement | |||||
| Operating cash flow | $712.00M | $848.00M | $500.00M | $602.00M | $710.00M |
| Capital expenditure | $139.00M | $148.00M | $147.00M | $96.00M | $79.00M |
| Free cash flow | $573.00M | $700.00M | $353.00M | $506.00M | $631.00M |
| Investing cash flow | -$400.00M | -$430.00M | -$1.14B | -$276.00M | -$677.00M |
| Financing cash flow | -$188.00M | -$510.00M | $701.00M | -$315.00M | -$333.00M |
| Depreciation & amortization | $311.00M | $297.00M | $248.00M | $212.00M | $210.00M |
| Stock-based compensation | $39.00M | $39.00M | $39.00M | $54.00M | $78.00M |
| Share buybacks | $850.00M | $385.00M | $250.00M | $485.00M | $401.00M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.